Target Price | $6.30 |
Price | $4.65 |
Potential |
35.48%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target Vivos Therapeutics Inc 2025 .
The average Vivos Therapeutics Inc target price is $6.30.
This is
35.48%
register free of charge
$6.60
41.94%
register free of charge
$6.00
29.03%
register free of charge
|
|
A rating was issued by 2 analysts: 2 Analysts recommend Vivos Therapeutics Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Vivos Therapeutics Inc stock has an average upside potential 2025 of
35.48%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 13.80 | 15.20 |
13.86% | 10.16% | |
EBITDA Margin | -120.87% | -72.36% |
20.51% | 40.13% |
2 Analysts have issued a sales forecast Vivos Therapeutics Inc 2024 . The average Vivos Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Vivos Therapeutics Inc 2024 . The average Vivos Therapeutics Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
EV/Sales | 1.17 |
Based on analysts' sales estimates for 2024, the Vivos Therapeutics Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Vivos Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.